PTEN promoter methylation in sporadic thyroid carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• The PTEN/MMAC1 tumor-suppressor gene is crucial for preventing various human tumors.
• PTEN inactivation is necessary for tumor suppression, with both alleles typically affected.
• Epigenetic mechanisms like promoter hypermethylation are suspected to inactivate PTEN in thyroid tumors, as mutations are less frequent.

Purpose of the Study:

• To determine the frequency of PTEN promoter hypermethylation in different types of thyroid tumors.
• To investigate the association between PTEN promoter hypermethylation and PTEN protein expression in thyroid tissues.

Main Methods:

• Analysis of frozen tissue samples from papillary carcinomas, follicular carcinomas, follicular adenomas, and normal thyroid tissues.
• Methylation-specific polymerase-chain reaction (PCR) was employed to detect PTEN promoter hypermethylation.
• Immunohistochemical staining was used to assess PTEN protein expression.

Main Results:

• PTEN promoter hypermethylation was detected in 45.7% of papillary carcinomas, 85.7% of follicular carcinomas, and 83.3% of follicular adenomas.
• Hypermethylation was absent in all normal thyroid tissue samples.
• A significant association was observed between negative PTEN immunohistochemical staining and the presence of promoter hypermethylation (p < 0.001).

Conclusions:

• PTEN promoter hypermethylation occurs at a high frequency in thyroid tumors, especially follicular types.
• Epigenetic silencing of PTEN via hypermethylation is a likely mechanism contributing to thyroid tumorigenesis.
• These findings highlight the potential role of PTEN inactivation in the development of thyroid cancers.